# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BioRestorative Therapies announced before the market opened on Thursday that it engaged in substantive licensing discussions wi...
Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical stage biopharmaceutical company focused on developi...
ONMD: 66% | OneMedNet shares are trading higher after the company announced that it has entered into a non-exclusive three-year...